See also this year's filing and all EDGAR filings for this company.
PDF Report 0001739426_2019_RVL_Pharmaceuticals_plc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001739426, RVL Pharmaceuticals plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 172,385,068 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 591,244,539 |
| 2 | PropertyPlantAndEquipmentNet | 31,263,432 |
| 3 | remainder_Assets | 751,927 |
| 4 | LiabilitiesCurrent | 114,393,628 |
| 5 | LiabilitiesNoncurrent | 266,802,911 |
| 6 | remainder_Liabilities | 28,179,302 |
| 7 | CostOfGoodsAndServicesSold | 135,013,998 |
| 8 | SellingGeneralAndAdministrativeExpense | 74,242,509 |
| 9 | ResearchAndDevelopmentExpense | 48,761,494 |
| 10 | remainder_Expenses | 94,953,291 |
| 11 | remainder_Revenues | 263,701,349 |
| 12 | remainder_NetIncome | -20,126,323 |
| 13 | remainder_ComprehensiveNetIncome | -1,213,036 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 795,644,966 |
| 1 | Liabilities | 409,375,841 |
| 2 | Expenses | 352,971,292 |
| 3 | Revenues | 263,701,349 |
| 4 | StockholdersEquity | 386,269,125 |
| 5 | NetIncome | -109,396,266 |
| 6 | ComprehensiveNetIncome | -110,002,784 |
| 7 | BaseVar | 921,516,404 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.22 |
| 9 | EconomicCapitalRatio | 2.47 |
Edgar->Model Mapping
Feature Distribution
